Application of a Two-Phase Experiment Design and Optimization Method to Formulate Ciprofloxacin-Loaded Bovine Serum Albumin Nanoparticles with High-Entrapment Efficiency for Targeting Urinary Tract Infections

Vista sencilla de ítem
dc.creatorSánchez, Sofía V.
dc.creatorCruz Jorge, Erlen
dc.creatorNavarro M., Nicolás
dc.creatorGonzález, María José
dc.creatorVásquez, Ricardo
dc.creatorDel Canto, Felipe
dc.creatorScavone, Paola
dc.creatorArrua, Eva Carolina
dc.creatorMorales, Javier O.
dc.date2025-05
dc.date.accessioned2026-03-10T03:51:25Z
dc.date.available2026-03-10T03:51:25Z
dc.descriptionUrinary tract infections (UTIs), predominantly caused by uropathogenic Escherichia coli (UPEC), pose a global health concern due to rising antibiotic resistance and biofilm formation. Albumin nanoparticles (NPs) offer a promising strategy for UTI treatment, with site-specific selectivity, improved bioavailability, and sustained drug release. This study focused on developing an optimized method for formulating ciprofloxacin-loaded albumin nanoparticles (CPF-loaded BSA NPs) to treat UPEC and its biofilms effectively. A desolvation method was used to synthesize the nanoparticles, and a two-phase experimental design was used for optimization. Evaluation parameters included size, polydispersity index, zeta potential, morphology, encapsulation efficiency, drug release, storage stability, cytotoxicity, and effectiveness against UPEC. The optimized CPF-loaded BSA NPs exhibited desirable characteristics such as small particle size (123 nm), low polydispersity index (0.178), optimum zeta potential (-31.8), and high encapsulation efficiency (> 80%). They also exhibited low cytotoxicity, high stability, and sustained drug release, making them an ideal drug delivery system. Critically, they demonstrated effectiveness against UPEC and its biofilm. This study suggests that the optimized CPF-loaded BSA NPs, synthesized usingour optimized desolvation technique, hold the potential for effectively treating UTIs caused by UPEC.
dc.descriptionFil: Sánchez, Sofía V.. Universidad de Chile; Chile
dc.descriptionFil: Cruz Jorge, Erlen. Instituto de Investigaciones Biológicas "Clemente Estable"; Uruguay
dc.descriptionFil: Navarro M., Nicolás. Instituto de Investigaciones Biológicas "Clemente Estable"; Uruguay
dc.descriptionFil: González, María José. Instituto de Investigaciones Biológicas "Clemente Estable"; Uruguay
dc.descriptionFil: Vásquez, Ricardo. Universidad de Chile; Chile
dc.descriptionFil: Del Canto, Felipe. Universidad de Chile; Chile
dc.descriptionFil: Scavone, Paola. Instituto de Investigaciones Biológicas "Clemente Estable"; Uruguay
dc.descriptionFil: Arrua, Eva Carolina. Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro de Investigacion y Desarrollo En Materiales Avanzados y Almacenamiento de Energia de Jujuy. - Universidad Nacional de Jujuy. Centro de Investigacion y Desarrollo En Materiales Avanzados y Almacenamiento de Energia de Jujuy. - Gobierno de la Provincia de Jujuy. Centro de Investigacion y Desarrollo En Materiales Avanzados y Almacenamiento de Energia de Jujuy; Argentina
dc.descriptionFil: Morales, Javier O.. Universidad de Chile; Chile
dc.formatapplication/pdf
dc.formatapplication/pdf
dc.identifierhttp://hdl.handle.net/11336/279363
dc.identifierSánchez, Sofía V.; Cruz Jorge, Erlen; Navarro M., Nicolás; González, María José; Vásquez, Ricardo; et al.; Application of a Two-Phase Experiment Design and Optimization Method to Formulate Ciprofloxacin-Loaded Bovine Serum Albumin Nanoparticles with High-Entrapment Efficiency for Targeting Urinary Tract Infections; Springer; AAPS Pharmscitech; 26; 5; 5-2025; 1-17
dc.identifier1530-9932
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://ri.unju.edu.ar/handle/123456789/608
dc.languageeng
dc.publisherSpringer
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://link.springer.com/10.1208/s12249-025-03115-6
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/10.1208/s12249-025-03115-6
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subjectBIOFILM ERADICATION
dc.subjectDRUG DELIVERY
dc.subjectNANOSTRUCTURES
dc.subjectURINARY TRACT INFECTION
dc.subjecthttps://purl.org/becyt/ford/1.4
dc.subjecthttps://purl.org/becyt/ford/1
dc.titleApplication of a Two-Phase Experiment Design and Optimization Method to Formulate Ciprofloxacin-Loaded Bovine Serum Albumin Nanoparticles with High-Entrapment Efficiency for Targeting Urinary Tract Infections
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion
Archivos
CC BY-NC-SA 4.0 Excepto donde se diga explícitamente, este ítem se publica bajo la siguiente licencia: Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
Colecciones
Artículos científicos(CIDMEJU)